172 related articles for article (PubMed ID: 3030773)
1. Mechanism of antagonism of thromboxane receptors in vascular smooth muscle.
Yanagisawa A; Smith JA; Brezinski ME; Lefer AM
Eur J Pharmacol; 1987 Jan; 133(1):89-96. PubMed ID: 3030773
[TBL] [Abstract][Full Text] [Related]
2. Characterization of contraction-mediating prostanoid receptors in human hand veins: effects of the thromboxane receptor antagonists BM13,505 and AH23848.
Arner M; Högestätt ED; Uski TK
Acta Physiol Scand; 1991 Jan; 141(1):79-86. PubMed ID: 2053448
[TBL] [Abstract][Full Text] [Related]
3. Novel angiotensin II AT(1) receptor antagonist irbesartan prevents thromboxane A(2)-induced vasoconstriction in canine coronary arteries and human platelet aggregation.
Li P; Fukuhara M; Diz DI; Ferrario CM; Brosnihan KB
J Pharmacol Exp Ther; 2000 Jan; 292(1):238-46. PubMed ID: 10604953
[TBL] [Abstract][Full Text] [Related]
4. Vasoactive effects of eicosapentaenoic acid on isolated vascular smooth muscle.
Yanagisawa A; Lefer AM
Basic Res Cardiol; 1987; 82(2):186-96. PubMed ID: 3038070
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of thromboxane actions in the isolated perfused rat heart.
Stahl GL; Darius H; Lefer AM
Life Sci; 1986 Jun; 38(22):2037-41. PubMed ID: 2940431
[TBL] [Abstract][Full Text] [Related]
6. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505.
Sjöberg T; Steen S
Acta Physiol Scand; 1989 Jun; 136(2):161-5. PubMed ID: 2528885
[TBL] [Abstract][Full Text] [Related]
7. Two mechanisms mediate relaxation by bradykinin of pig coronary artery: NO-dependent and -independent responses.
Cowan CL; Cohen RA
Am J Physiol; 1991 Sep; 261(3 Pt 2):H830-5. PubMed ID: 1653538
[TBL] [Abstract][Full Text] [Related]
8. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
Ogletree ML; Allen GT
J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
[TBL] [Abstract][Full Text] [Related]
9. Actions of the novel thromboxane A2 receptor antagonist sodium (E)-11-[2-(5,6-dimethyl-1-benzimidazolyl)-ethylidene]-6,11- dihydrodibenz[b,e]oxepine-1-carboxylate monohydrate on smooth muscle preparations.
Karasawa A; Shirakura S; Higo K; Kubo K
Arzneimittelforschung; 1991 Dec; 41(12):1237-41. PubMed ID: 1815522
[TBL] [Abstract][Full Text] [Related]
10. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
Quilley J; McGiff JC; Nasjletti A
Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
[TBL] [Abstract][Full Text] [Related]
11. Inhibitory effects of the selective thromboxane receptor antagonist BM 13.177 on platelet aggregation, vasoconstriction and sudden death.
Patscheke H; Stegmeier K; Müller-Beckmann B; Sponer G; Staiger C; Neugebauer G
Biomed Biochim Acta; 1984; 43(8-9):S312-8. PubMed ID: 6097235
[TBL] [Abstract][Full Text] [Related]
12. Effect of trimetoquinol analogs for antagonism of endoperoxide/thromboxane A2-mediated responses in human platelets and rat aorta.
Mukhopadhyay A; Navran SS; Amin HM; Abdel-Aziz SA; Chang J; Sober DJ; Miller DD; Feller DR
J Pharmacol Exp Ther; 1985 Jan; 232(1):1-9. PubMed ID: 3855323
[TBL] [Abstract][Full Text] [Related]
13. GR32191, a highly potent and specific thromboxane A2 receptor blocking drug on platelets and vascular and airways smooth muscle in vitro.
Lumley P; White BP; Humphrey PP
Br J Pharmacol; 1989 Jul; 97(3):783-94. PubMed ID: 2527074
[TBL] [Abstract][Full Text] [Related]
14. Different potency of endothelium-derived relaxing factors against thromboxane, endothelin, and potassium chloride in intramyocardial porcine coronary arteries.
Noll G; Bühler FR; Yang Z; Lüscher TF
J Cardiovasc Pharmacol; 1991 Jul; 18(1):120-6. PubMed ID: 1719280
[TBL] [Abstract][Full Text] [Related]
15. Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.
Fujiwara T; Angus JA
Br J Pharmacol; 1996 Dec; 119(8):1549-56. PubMed ID: 8982500
[TBL] [Abstract][Full Text] [Related]
16. Protective effects of the thromboxane receptor antagonists BM 13.177 and BM 13.505 against U 46619-induced sudden death in rats.
Smith EF; McDonald J
Pharmacology; 1988; 36(5):340-7. PubMed ID: 3406046
[TBL] [Abstract][Full Text] [Related]
17. Cinnamophilin, a novel thromboxane A2 receptor antagonist, isolated from Cinnamomum philippinense.
Yu SM; Ko FN; Wu TS; Lee JY; Teng CM
Eur J Pharmacol; 1994 Apr; 256(1):85-91. PubMed ID: 8026563
[TBL] [Abstract][Full Text] [Related]
18. Actions of a novel thromboxane A2-receptor antagonist, S-145, on isolated monkey and cat arteries.
Nakajima M; Ueda M
J Cardiovasc Pharmacol; 1989 Sep; 14(3):502-9. PubMed ID: 2476633
[TBL] [Abstract][Full Text] [Related]
19. Pharmacological reactivity of human epicardial coronary arteries: characterization of relaxation responses to endothelium-derived relaxing factor.
Stork AP; Cocks TM
Br J Pharmacol; 1994 Dec; 113(4):1099-104. PubMed ID: 7889260
[TBL] [Abstract][Full Text] [Related]
20. BAY u3405, a potent and selective thromboxane A2 receptor antagonist on airway smooth muscle in vitro.
McKenniff MG; Norman P; Cuthbert NJ; Gardiner PJ
Br J Pharmacol; 1991 Nov; 104(3):585-90. PubMed ID: 1839139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
